Contract facts
FederalIGF OT IGF is a federal award for Fda Office Of Acq Grant Svcs held by Drt Strategies, Inc. Estimated value $3.8M ($-8,138.25 obligated). Current period of performance ends Aug 4, 2019. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.
Recompete timing
PublicCurrent PoP ended Aug 4, 2019 (2574 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordDrt Strategies, Inc — $40.5M obligated across 37 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40118F10122?
75F40118F10122 (IGF OT IGF) is a Fda Office Of Acq Grant Svcs award with a potential value of $3.8M, currently held by Drt Strategies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40118F10122?
Fda Office Of Acq Grant Svcs awarded 75F40118F10122 to Drt Strategies, Inc (potential $3.8M).
Who is the incumbent on 75F40118F10122?
Drt Strategies, Inc is the incumbent with $40.5M across 37 related awards in SCOUT’s public footprint. The current period of performance ends Aug 4, 2019.
When does Drt Strategies, Inc’s 75F40118F10122 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 4, 2019. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.